Granulocyte concentrates: how can we assess their quality?
The use of granulocyte transfusions to treat and prevent life-threatening infection in patients lacking neutrophil numbers or function may become increasingly important in aiding advances in the treatment of haematological malignancies. A critical factor in determining the outcome of granulocyte transfusion is the number of cells transfused, and collection of sufficiently high concentration of cells from donors remains challenging. A number of tests of granulocyte function can be performed in vitro to assess the quality of granulocyte concentrates, which may be useful in helping to optimize granulocyte collection, processing and storage methods. Studies that have examined neutrophil function in granulocyte concentrates to date have tended to focus on the assessment of viability, chemotaxis, phagocytosis and oxidative killing. How useful in vitro tests of neutrophil function are in predicting neutrophil function following granulocyte transfusion remains to be established in conjunction with well-designed clinical trials.
Bashir
S
S
National Blood Service, Brentwood, Essex, UK. saber.bashir@nbs.nhs.uk
Cardigan
R
R
D001793:Blood Preservation; D019411:Clinical Laboratory Techniques; D006098:Granulocytes / Q000637:transplantation*; D006801:Humans; D017708:Leukocyte Transfusion / Q000592:standards*; D009504:Neutrophils / Q000166:cytology / Q000502:physiology